Long Island City biotech startup Envisagenics raises $25M in Series B funding to develop cancer therapies.
Saved in:
| Title: | Long Island City biotech startup Envisagenics raises $25M in Series B funding to develop cancer therapies. |
|---|---|
| Authors: | D'Ambrosio, Amanda (AUTHOR) |
| Source: | Crain's New York Business. 6/17/2024, Vol. 40 Issue 24, p6-6. 1p. |
| Database: | Business Source Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
